ABK Closed US$35M Round Last Year
ABK Biomedical late last year raised US$35 million (C$47.9 million) in a Series D financing round to support clinical trials, manufacturing expansion and development of a product to be used in treating liver cancer.
The Halifax-based medical device company said the oversubscribed round was led by J.P. Morgan Life Sciences Private Capital, investing in the company for the first time. Existing